BioTurku company licenses biomaterial technology to Bayer
BioTurku company licenses biomaterial technology to BayerTurku Science Park -based DelSiTech Ltd and Bayer Innovation GmbH (Düsseldorf, Germany) have announced that they have entered into a license agreement. The agreement enables Bayer the exclusive rights to use the unique and proprietary DelSiTech ® drug delivery technology for fiber applications in the fields of wound care and certain other applications.
Under the terms of the agreement DelSiTech will receive a signing fee, milestone payments and further royalties for future sales of the products using the DelSiTech technology. The agreement contains also an option for further collaboration.
16 May 2023
Workshop"AI in clinical diagnostics: challenges and opportunities"| 7 June 2023 17:30-19:00 CET (Hybrid)